参考文献/References:
[1] 潘中允.临床实用核医学[M].北京:人民卫生出版社,2013.
[2] 黄刚.核医学与分子影像临床操作规范[M].北京:人民卫生出版社,2014.
[3] Coooer DS,Dohertv GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2006,16(2):109-142.
[4] 中华医学会核医学分会.131I治疗分化型甲状腺癌指南(2014版)[J].中华核医学与分子影像杂志,2014,34(4):264-278.
[5] Coooer DS,Doherty GM,Haugen BR,et al.Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2009,19(11):1167-1214.
[6] 中华医学会内分泌分会,中华医学会外科分会,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17):1249-1272.
[7] Mallick U,Harmer C,Yap B,et al.Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.N Engl J Med,2012.366(18):1674-1685.
[8] Schlumberger M,Catargi B,Borget I,et al.Strategies of radioiodine ablation in patients with low-risk thyroid cancer.N Engl J Med,2012,366(18):1663-1673.